Bayer says Alzheimer test shown to work in study (Reuters)

Reuters - Bayer’s Alzheimer’s disease (AD) marker florbetaben was shown to help detect the illness in eight out of 10 cases in a Phase II study, possibly offering a way to diagnose early onset.

This entry was posted on Sunday, July 12th, 2009 at 3:55 pm and is filed under Health. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.